288 related articles for article (PubMed ID: 27497970)
1. "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.
Butz LB; Sullivan SE; Chandler WF; Barkan AL
Pituitary; 2016 Dec; 19(6):547-551. PubMed ID: 27497970
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
3. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, Clinical and Biochemical Spectrum, and Treatment Outcome of Acromegaly With Normal Basal GH at Diagnosis.
Espinosa de Los Monteros AL; Sosa-Eroza E; Gonzalez B; Mendoza V; Mercado M
J Clin Endocrinol Metab; 2018 Oct; 103(10):3919-3924. PubMed ID: 30060172
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of acromegaly in hospitalized patients with type 2 diabetes.
Suda K; Fukuoka H; Iguchi G; Hirota Y; Nishizawa H; Bando H; Matsumoto R; Takahashi M; Sakaguchi K; Takahashi Y
Endocr J; 2015; 62(1):53-9. PubMed ID: 25284247
[TBL] [Abstract][Full Text] [Related]
7. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
[TBL] [Abstract][Full Text] [Related]
8. "Micromegaly": Acromegaly with apparently normal GH, an entity on its own?
Vilar L; Naves LA; Martins MRA; Ribeiro-Oliveira A
Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101878. PubMed ID: 38519400
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
Dimaraki EV; Jaffe CA; DeMott-Friberg R; Chandler WF; Barkan AL
J Clin Endocrinol Metab; 2002 Aug; 87(8):3537-42. PubMed ID: 12161471
[TBL] [Abstract][Full Text] [Related]
10. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
11. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
12. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly.
Park SH; Ku CR; Moon JH; Kim EH; Kim SH; Lee EJ
J Clin Endocrinol Metab; 2018 Mar; 103(3):909-916. PubMed ID: 29272449
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and complications of neurosurgical treatment of acromegaly.
Krzentowska-Korek A; Gołkowski F; Bałdys-Waligórska A; Hubalewska-Dydejczyk A
Pituitary; 2011 Jun; 14(2):157-62. PubMed ID: 21107739
[TBL] [Abstract][Full Text] [Related]
14. [Acromegaly and pregnancy: report of six new cases].
Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of acromegaly in Ecuador.
López Gavilanez E; Guerrero Franco K; Solórzano Zambrano N; Navarro Chávez M; López Estrella C; Vaca Burbano L; Marriott Díaz E
Endocrinol Nutr; 2016; 63(7):333-8. PubMed ID: 27158065
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly without imaging evidence of pituitary adenoma.
Lonser RR; Kindzelski BA; Mehta GU; Jane JA; Oldfield EH
J Clin Endocrinol Metab; 2010 Sep; 95(9):4192-6. PubMed ID: 20610592
[TBL] [Abstract][Full Text] [Related]
17. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic trends and outcome of acromegaly: a single center experience over a 40-year period.
Karapanou O; Tzanela M; Christoforaki M; Papastathopoulou L; Moutsatsou P; Botoula E; Tsagarakis S
Hormones (Athens); 2016 Jul; 15(3):368-376. PubMed ID: 27394702
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and treatment outcomes of micromegaly - acromegaly with apparently normal basal GH: A retrospective study and literature review.
Inacio I; Fonseca L; Amado A; Benido V; Ribeiro I; Dores J; Amaral C; Cardoso MH
Endocr Regul; 2022 Apr; 56(2):87-94. PubMed ID: 35489048
[No Abstract] [Full Text] [Related]
20. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
